What is the recommended dosage of Piptaz (Piperacillin/Tazobactam) for pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pediatric Dosing of Piperacillin-Tazobactam (Piptaz)

For pediatric patients 9 months and older, administer piperacillin-tazobactam at 100 mg/kg (of piperacillin component) every 8 hours for appendicitis/peritonitis and every 6 hours for nosocomial pneumonia; for infants 2-9 months, reduce the dose to 80 mg/kg every 8 hours for appendicitis/peritonitis and every 6 hours for nosocomial pneumonia. 1

Standard Dosing by Age and Indication

Infants 2-9 Months

  • Appendicitis/Peritonitis: 90 mg/kg (80 mg piperacillin/10 mg tazobactam) every 8 hours 1
  • Nosocomial Pneumonia: 90 mg/kg (80 mg piperacillin/10 mg tazobactam) every 6 hours 1
  • The dose reduction in this age group accounts for immature renal function, which affects drug clearance 2

Children >9 Months to 40 kg

  • Appendicitis/Peritonitis: 112.5 mg/kg (100 mg piperacillin/12.5 mg tazobactam) every 8 hours 1
  • Nosocomial Pneumonia: 112.5 mg/kg (100 mg piperacillin/12.5 mg tazobactam) every 6 hours 1

Children >40 kg

  • Use adult dosing: 3.375 g every 6 hours for most infections, or 4.5 g every 6 hours for nosocomial pneumonia 1

Alternative Guideline-Based Dosing

For complicated intra-abdominal infections, the Surgical Infection Society and IDSA recommend a broader dosing range of 200-300 mg/kg/day (of piperacillin component) divided every 6-8 hours 3. This higher dosing range may be appropriate for severe infections or when undrained abscesses are present 3.

Maximum Daily Dose

The maximum daily dose should not exceed 24,000 mg/day (based on piperacillin component), regardless of weight-based calculations 4.

Administration Details

  • Infusion time: Administer by intravenous infusion over 30 minutes 1
  • Duration of therapy: Typically 7-10 days for most infections 1
  • Renal impairment: Dosing adjustments have not been established for pediatric patients with renal impairment 1

Critical Considerations for Optimal Dosing

Extended Infusions for Resistant Organisms

Standard 0.5-hour infusions may be inadequate for organisms with higher MICs (≥16 mg/L), particularly in children older than 6 months 5. For infections caused by organisms with MICs of 16 mg/L:

  • Infants 2-6 months: 90 mg/kg every 8 hours as a 2-hour infusion achieves optimal target attainment 5
  • Children >6 months to 6 years: 100 mg/kg every 8 hours as a 4-hour infusion achieves optimal target attainment 5

For critically ill children aged 1-6 years with suspected Pseudomonas aeruginosa (MIC 16-32 mg/L), 100 mg/kg every 6 hours as a 3-hour prolonged infusion or 400 mg/kg as a 24-hour continuous infusion are the only regimens that achieve optimal pharmacodynamic targets 6.

Common Pitfalls to Avoid

  • Do not use the same dose for all age groups: Infants 2-9 months require dose reduction due to immature renal function 2
  • Do not underdose nosocomial pneumonia: This indication requires more frequent dosing (every 6 hours vs every 8 hours) 1
  • Do not use standard infusions for resistant organisms: Consider extended infusions (2-4 hours) when MICs are ≥16 mg/L 6, 5
  • Do not mix with aminoglycosides in the same solution: These must be reconstituted and administered separately, though Y-site co-administration is acceptable under certain conditions 1

References

Research

Optimising piperacillin/tazobactam dosing in paediatrics.

International journal of antimicrobial agents, 2007

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pediatric Dosing of Piperacillin-Tazobactam

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Dose-Exposure Simulation for Piperacillin-Tazobactam Dosing Strategies in Infants and Young Children.

Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.